Publication | Open Access
RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer
18
Citations
29
References
2013
Year
Breast OncologyMedicinePharmacologyPathologyPhase Ii StudyBreast CancerCancer TreatmentAdjuvant TherapyOncologyRadiation OncologyMolecular Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1